Ping An Biomedical director named in Form 3

Ping An Biomedical Co., Ltd. filed a Form 3 identifying Liu Xianzhi (XZL) as a director and reporting person.

Rhea-AI Filing Summary

Ping An Biomedical Co., Ltd. filed a Form 3 identifying Liu Xianzhi (XZL) as a director and reporting person. The filing does not list any insider purchase, sale, or other equity transaction, and shows no derivative positions or holding entries in this report.

Key Figures

Net insider share transactions: 0 shares Insider buy transactions: 0 Insider sell transactions: 0

3 metrics

Net insider share transactions 0 shares Net buy/sell shares in Form 3 transaction summary

Insider buy transactions 0 BuyCount and buyShares reported in transactionSummary

Insider sell transactions 0 SellCount and sellShares reported in transactionSummary

Key Terms

reporting persons, ten percent owner, transactionSummary, derivativeSummary

4 terms

reporting persons financial

""reportingPersons": [ { "name": "Liu Xianzhi (XZL)""

ten percent owner financial

""is_ten_percent_owner": 0"

transactionSummary financial

""transactionSummary": { "buyCount": 0, "sellCount": 0"

derivativeSummary financial

""derivativeSummary": []"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Ping An Biomedical (PASW) Form 3 report about Liu Xianzhi?

The Form 3 shows that Liu Xianzhi (XZL) is a director and reporting person of Ping An Biomedical Co., Ltd.. The filing reports no equity holdings, transactions, or derivative positions in this submission.

Does the Ping An Biomedical Form 3 show any insider trades?

No insider trades are shown in this Form 3 for Ping An Biomedical Co., Ltd.. Transaction counts for buys, sells, exercises, gifts, tax withholding, and restructurings are all reported as zero in the summary data.

Are any derivative securities reported for Liu Xianzhi in PASW’s Form 3?

No derivative securities are reported for Liu Xianzhi in this Form 3. The derivative summary section is empty, and derivative transaction counts and exercise share totals are listed as zero for this reporting person.

Does Ping An Biomedical’s Form 3 indicate any large ownership position by Liu Xianzhi?

The Form 3 identifies Liu Xianzhi as a director but shows no holding entries. The ten percent owner flag is set to 0, indicating Liu is not reported here as a ten percent owner of Ping An Biomedical’s equity.

What is the net buy or sell activity in this Ping An Biomedical Form 3?

The net buy or sell activity is reported as zero shares with a neutral net direction. All transaction-related share counts, including buys, sells, exercises, and gifts, are listed as zero in the transaction summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 06:05 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Xianzhi (XZL)

(Last) (First) (Middle)

UNIT 2, BUILDING 3, LIUTANG APARTMENT,

XIANGJISI ROAD, GONGSHU DISTRICT

(Street)

HANGZHOU CITY ZHEJIANG PROVINCE 310000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
10/14/2025

3. Issuer Name and Ticker or Trading Symbol
Ping An Biomedical Co., Ltd. [ PASW ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Xianzhi Liu	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)